Exact Mass: 379.1756646

Exact Mass Matches: 379.1756646

Found 99 metabolites which its exact mass value is equals to given mass value 379.1756646, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Korupensamin b

Korupensamine A

C23H25NO4 (379.178349)


   

Dioncopeltin a

Dioncopeltine A

C23H25NO4 (379.178349)


   

Dioncophyllinol B

Dioncophyllinol B

C23H25NO4 (379.178349)


   

sudan 7b

N-Ethyl-1-[2-[4-(2-phenyldiazenyl)phenyl]diazenyl]-2-naphthalenamine

C24H21N5 (379.1796866)


   

droperidol

droperidol

C22H22FN3O2 (379.1695964)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C323 - Butyrophenone D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; INTERNAL_ID 1207 INTERNAL_ID 1207; CONFIDENCE standard compound CONFIDENCE standard compound; EAWAG_UCHEM_ID 3679 Droperidol is a butyrophenone-type Dopamine-2 receptor antagonist.

   

Droperidol

1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one

C22H22FN3O2 (379.1695964)


A butyrophenone with general properties similar to those of haloperidol. It is used in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593) D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C323 - Butyrophenone D005765 - Gastrointestinal Agents > D000932 - Antiemetics Droperidol is a butyrophenone-type Dopamine-2 receptor antagonist.

   

4H-1-Benzopyran-8-acetic acid, 4-oxo-2-phenyl-, 2-(diethylamino)ethyl ester

4H-1-Benzopyran-8-acetic acid, 4-oxo-2-phenyl-, 2-(diethylamino)ethyl ester

C23H25NO4 (379.178349)


   

Merafloxacin

1-ethyl-7-{3-[(ethylamino)methyl]pyrrolidin-1-yl}-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C19H23F2N3O3 (379.17073919999996)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

   

Sudan Red 7B

N-ethyl-1-{2-[4-(2-phenyldiazen-1-yl)phenyl]diazen-1-yl}naphthalen-2-amine

C24H21N5 (379.1796866)


   

8H-Purin-8-one, 7-(2-butynyl)-7,9-dihydro-9-(6-methoxy-3-pyridinyl)-6-(1-piperazinyl)-

7-(but-2-yn-1-yl)-9-(6-methoxypyridin-3-yl)-6-(piperazin-1-yl)-8,9-dihydro-7H-purin-8-one

C19H21N7O2 (379.1756646)


   

2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide

2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide

C25H21N3O (379.1684536)


   
   

7-Demethoxytylophorine N-oxide

7-Demethoxytylophorine N-oxide

C23H25NO4 (379.178349)


   
   

(+-)-Pergularinine

(+-)-Pergularinine

C23H25NO4 (379.178349)


   
   
   
   
   
   
   

dioncophyllinol D

dioncophyllinol D

C23H25NO4 (379.178349)


   

14-hydroxy-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydro-dibenzo(f,h)-pyrrolo(1,2-b)-isochinolin

14-hydroxy-2,3,6-trimethoxy-9,11,12,13,13a,14-hexahydro-dibenzo(f,h)-pyrrolo(1,2-b)-isochinolin

C23H25NO4 (379.178349)


   

3-ethoxy-5-ethyl-4,5-dihydro-1-methoxy-4-oxodibenz(cd,f)indol-2-carboxylic acid ethyl ester

3-ethoxy-5-ethyl-4,5-dihydro-1-methoxy-4-oxodibenz(cd,f)indol-2-carboxylic acid ethyl ester

C23H25NO4 (379.178349)


   
   
   
   

1,3,8-trihydroxy-2,7-bis-(3-methyl-but-2-enyl)-10H-acridin-9-one|Atalaphyllidin|Atalaphyllidine+|Atalaphyllin

1,3,8-trihydroxy-2,7-bis-(3-methyl-but-2-enyl)-10H-acridin-9-one|Atalaphyllidin|Atalaphyllidine+|Atalaphyllin

C23H25NO4 (379.178349)


   

cycloatalaphylline A

cycloatalaphylline A

C23H25NO4 (379.178349)


   

4-desmethylisotylocrebrine|4-Hydroxy-3,6,7-trimethoxyphenanthroindolizidine

4-desmethylisotylocrebrine|4-Hydroxy-3,6,7-trimethoxyphenanthroindolizidine

C23H25NO4 (379.178349)


   
   
   
   
   
   
   
   
   

1,3,5-trihydroxy-2,4-bis(3-methylbut-2-enyl)-10H-acridin-9-one

NCGC00385469-01!1,3,5-trihydroxy-2,4-bis(3-methylbut-2-enyl)-10H-acridin-9-one

C23H25NO4 (379.178349)


   
   
   
   
   
   

6-CHLORO-2-HEXANONE

6-CHLORO-2-HEXANONE

C18H25N3O6 (379.174327)


   
   

N-[3-(dimethylamino)propyl]-2-methylprop-2-enamide,1-ethenylpyrrolidin-2-one,sulfuric acid

N-[3-(dimethylamino)propyl]-2-methylprop-2-enamide,1-ethenylpyrrolidin-2-one,sulfuric acid

C15H29N3O6S (379.17769740000006)


   

Fmoc-trans-4-Amc-OH

Fmoc-trans-4-Amc-OH

C23H25NO4 (379.178349)


   
   

Fmoc-L-Cycpentala-OH

Fmoc-L-Cycpentala-OH

C23H25NO4 (379.178349)


   

Frovatriptan

Frovatriptan Succinate monohydrate

C18H25N3O6 (379.174327)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Frovatriptan succinate hydrate ((R)-Frovatriptan succinate hydrate) is a potent, high affinity, selective and orally active 5-HT1B (pK50 of 8.2) and 5-HT1D receptor agonist. Frovatriptan succinate hydrate exhibits >10-fold selectivity for 5-HT1B and 5-HT1D over 5-HT1A, 5-HT1F, and 5-HT7 and >1000-fold selectivity over other 5-HT, dopamine, histamine H1, and α1-adrenoceptor. Frovatriptan succinate hydrate has the potential for migraine research[1][2].

   

Fmoc-cis-4-aminocyclohexane acetic acid

Fmoc-cis-4-aminocyclohexane acetic acid

C23H25NO4 (379.178349)


   

(2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-6-heptenoic acid

(2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-6-heptenoic acid

C23H25NO4 (379.178349)


   

(E)-2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-FURO[3,2-B]PYRIDINE-6-CARBALDEHYDE OXIME

(E)-2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)-FURO[3,2-B]PYRIDINE-6-CARBALDEHYDE OXIME

C23H25NO4 (379.178349)


   
   

FMOC-1-AMINO-1-CYCLOHEPTANECARBOXYLIC ACID

FMOC-1-AMINO-1-CYCLOHEPTANECARBOXYLIC ACID

C23H25NO4 (379.178349)


   

FMoc-(R)-2-aMino-3-cyclopentylpropanoic acid

FMoc-(R)-2-aMino-3-cyclopentylpropanoic acid

C23H25NO4 (379.178349)


   

N-(2-hydroxy-1-methyl-2-phenylethyl)-N,7,7-trimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulphonamide

N-(2-hydroxy-1-methyl-2-phenylethyl)-N,7,7-trimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulphonamide

C20H29NO4S (379.1817194000001)


   

3-[1-(9H-fluoren-9-ylmethoxycarbonyl)piperidin-4-yl]propanoic acid

3-[1-(9H-fluoren-9-ylmethoxycarbonyl)piperidin-4-yl]propanoic acid

C23H25NO4 (379.178349)


   

(3S)-3-cyclopentyl-3-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid

(3S)-3-cyclopentyl-3-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid

C23H25NO4 (379.178349)


   

Wnt-C59(C59)

2-(4-(2-Methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide

C25H21N3O (379.1684536)


   

Fmoc-(S)-2-(4-pentenyl)Ala-OH

Fmoc-(S)-2-(4-pentenyl)Ala-OH

C23H25NO4 (379.178349)


   
   

(S)-N-Fmoc-2-(5-hexenyl)glycine

(S)-N-Fmoc-2-(5-hexenyl)glycine

C23H25NO4 (379.178349)


   
   

6-N-BUTYL-2-(3,4-DIMETHOXYPHENYL)-8-METHYLQUINOLINE-4-CARBOXYLIC ACID

6-N-BUTYL-2-(3,4-DIMETHOXYPHENYL)-8-METHYLQUINOLINE-4-CARBOXYLIC ACID

C23H25NO4 (379.178349)


   

8H-Purin-8-one, 7-(2-butynyl)-7,9-dihydro-9-(6-methoxy-3-pyridinyl)-6-(1-piperazinyl)-

8H-Purin-8-one, 7-(2-butynyl)-7,9-dihydro-9-(6-methoxy-3-pyridinyl)-6-(1-piperazinyl)-

C19H21N7O2 (379.1756646)


   
   

7-Hydroxy-3-(2-methoxyphenyl)-8-[(4-methyl-1-piperidinyl)methyl]-1-benzopyran-4-one

7-Hydroxy-3-(2-methoxyphenyl)-8-[(4-methyl-1-piperidinyl)methyl]-1-benzopyran-4-one

C23H25NO4 (379.178349)


   

2-[[Cyclohexyl(oxo)methyl]amino]acetic acid (2-oxo-1,2-diphenylethyl) ester

2-[[Cyclohexyl(oxo)methyl]amino]acetic acid (2-oxo-1,2-diphenylethyl) ester

C23H25NO4 (379.178349)


   
   

Phe-Val-Asp

Phe-Val-Asp

C18H25N3O6 (379.174327)


A tripeptide composed of L-phenylalanine, L-valine, and L-aspartic acid joined by peptide linkages.

   

L-threonyl-L-prolyl-L-tyrosine

L-threonyl-L-prolyl-L-tyrosine

C18H25N3O6 (379.174327)


   

2-[[2-(4-Methoxyphenyl)-6-methyl-1-benzopyran-4-ylidene]amino]-4-methylpentanoic acid

2-[[2-(4-Methoxyphenyl)-6-methyl-1-benzopyran-4-ylidene]amino]-4-methylpentanoic acid

C23H25NO4 (379.178349)


   

4-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]-7-ethyl-1-benzopyran-2-one

4-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]-7-ethyl-1-benzopyran-2-one

C23H25NO4 (379.178349)


   
   
   

(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.171824)


   

(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.171824)


   

(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.171824)


   

(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.171824)


   

(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2S,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.171824)


   

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.171824)


   

(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

(2R,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile

C22H25N3OS (379.171824)


   
   
   
   
   
   
   
   
   

beta-D-Tyvp-(1->3)-beta-D-GalpNAc6,OMe2

beta-D-Tyvp-(1->3)-beta-D-GalpNAc6,OMe2

C16H29NO9 (379.1842224)


   

beta-D-Tyvp2Me-(1->3)-beta-D-GalpNAc-OMe

beta-D-Tyvp2Me-(1->3)-beta-D-GalpNAc-OMe

C16H29NO9 (379.1842224)


   

Triphyopeltine

Dioncopeltine A

C23H25NO4 (379.178349)


An isoquinoline alkaloid that is the biaryl resulting from substitution of the hydrogen at the 7-position of (1R,3R)-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol by a 1-hydroxy-6-(hydroxymethyl)-8-methoxynaphthalen-5-yl group. It is a naphthylisoquinoline alkaloid found in Triphyophyllum peltatum.

   

Thr-Pro-Tyr

Thr-Pro-Tyr

C18H25N3O6 (379.174327)


A tripeptide composed of L-threonine, L-proline, and L-tyrosine joined by peptide linkages.